Remyelination failure after a demyelinating episode is a key feature of MS.
Parenchymal and SVZ-derived OPCs form a remyelinating cell niche in the adult CNS.
Oligodendroglia have a myelin-independent role in neuronal survival and protection.
Oligodendrocyte-targeted therapeutic strategies to treat neurodegenerative diseases.